UPSENDLI Trademark
Trademark Overview
On Thursday, March 27, 2025, a trademark application was filed for UPSENDLI with the United States Patent and Trademark Office. The USPTO has given the UPSENDLI trademark a serial number of 99106858. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, October 1, 2025. This trademark is owned by Glaxo Group Limited. The UPSENDLI trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
General Information
| Serial Number | 99106858 |
| Word Mark | UPSENDLI |
| Filing Date | Thursday, March 27, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, October 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 27, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Thursday, March 27, 2025 | NEW APPLICATION ENTERED |
| Thursday, March 27, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 26, 2025 | ASSIGNED TO EXAMINER |
| Thursday, August 28, 2025 | SUSPENSION LETTER WRITTEN |
| Thursday, August 28, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, August 28, 2025 | LETTER OF SUSPENSION E-MAILED |
| Thursday, September 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 11, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
